Cellebrite DI Sees Q4 Sales $145.000M-$150.000M vs $151.451M Est
Benzinga Newsdesk 8 hours ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) sees Q4 sales of $145.000 million-$150.000 million vs $151.451 million analyst estimate.
Cellebrite DI (NASDAQ:CLBT) sees Q4 sales of $145.000 million-$150.000 million vs $151.451 million analyst estimate.